Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.

Kojima S, Iwamoto T, Kobayashi Y, Kato M, Takizawa F, Ida T, Suzuki J, Toda Y, Miyachi K, Iwata A, Furuta S, Ikeda K, Nakajima H

Open source

DOI
10.1136/rmdopen-2023-003902
Published
2024 Feb 21
Container
RMD open
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/rmdopen-2023-003902,
  title = {Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.},
  author = {Kojima S and Iwamoto T and Kobayashi Y and Kato M and Takizawa F and Ida T and Suzuki J and Toda Y and Miyachi K and Iwata A and Furuta S and Ikeda K and Nakajima H},
  year = {2024},
  journal = {RMD open},
  doi = {10.1136/rmdopen-2023-003902},
  url = {https://doi.org/10.1136/rmdopen-2023-003902}
}

RIS

TY  - JOUR
TI  - Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.
AU  - Kojima S
AU  - Iwamoto T
AU  - Kobayashi Y
AU  - Kato M
AU  - Takizawa F
AU  - Ida T
AU  - Suzuki J
AU  - Toda Y
AU  - Miyachi K
AU  - Iwata A
AU  - Furuta S
AU  - Ikeda K
AU  - Nakajima H
PY  - 2024
JO  - RMD open
DO  - 10.1136/rmdopen-2023-003902
UR  - https://doi.org/10.1136/rmdopen-2023-003902
ER  - 

APA

S, K., T, I., Y, K., M, K., F, T., T, I., J, S., Y, T., K, M., A, I., S, F., K, I., & H, N. (2024). Immunogenicity and influence on disease activity of recombinant zoster vaccine in patients with rheumatoid arthritis treated with DMARDs.. RMD open. https://doi.org/10.1136/rmdopen-2023-003902

Source records